JACC: Case Reports (Jul 2024)

Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection

  • Stefanos Zafeiropoulos, MD, PhD,
  • Nicholas J. Beccarino, MD,
  • Stavros Stavrakis, MD, PhD,
  • Stavros Zanos, MD, PhD,
  • Raman Mitra, MD, PhD

Journal volume & issue
Vol. 29, no. 13
p. 102373

Abstract

Read online

Cardioneuroablation is a novel approach to treat patients with recurrent vasovagal syncope (VVS), targeting the ganglionated plexi around the atria and thus reducing the vagal input to the heart. This study reports a case of drug-refractory VVS after COVID-19 infection, successfully managed with cardioneuroablation.

Keywords